FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

7 results

alendronate
(ALENDRONATE SODIUM)
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Usage: Alendronate sodium tablets are indicated for treating and preventing osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, treating glucocorticoid-induced osteoporosis, and treating Paget’s disease of bone. Use should be periodically re-evaluated, particularly for low-risk fracture patients after 3 to 5 years.
alendronate
(Alendronate sodium tablet)
Marlex Pharmaceuticals Inc
Usage: Alendronate sodium is indicated for treating osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, preventing postmenopausal osteoporosis, treating glucocorticoid-induced osteoporosis, and managing Paget's disease of bone in symptomatic patients or those at risk for complications. Reinforcement of therapy need is recommended periodically.
calcitonin salmon
(Calcitonin Salmon)
ENDO USA, Inc.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget's disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients who cannot use alternative therapies. Its efficacy in fracture reduction for osteoporosis is not established, and ongoing therapy should be periodically re-evaluated due to potential malignancy risks.
calcitonin salmon
(CALCITONIN SALMON)
Cipla USA Inc.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in women more than five years postmenopause. It is intended for patients who do not respond to, or cannot use, alternative treatments. Regular re-evaluation is recommended due to potential malignancy risks.
miacalcin
(calcitonin salmon)
Mylan Institutional LLC
Usage: Miacalcin injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients unsuitable for alternative therapies. Its use should be periodically re-evaluated due to potential malignancy associations. No fracture reduction efficacy has been demonstrated for osteoporosis treatment.
miacalcin
(calcitonin salmon)
Mylan Institutional LLC
Usage: Miacalcin injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients who cannot tolerate or are unsuitable for alternative therapies. Its long-term use requires periodic re-evaluation due to potential malignancy risks.
zoledronic acid
(Zoledronic Acid)
Mylan Institutional LLC
Usage: Zoledronic acid injection is indicated for the treatment of Paget's disease of bone in adults. It is recommended for patients with elevated serum alkaline phosphatase, those who are symptomatic, or those at risk for complications from the disease.

Medications for Osteitis Deformans

alendronate

alendronate

calcitonin salmon

calcitonin salmon

miacalcin

miacalcin

zoledronic acid